

Gene-based medicines, in the form of DNA, RNA, and ribonuclear proteins, promise to help treat many diseases caused by genetic mutations. But one huge challenge of genetic medicine has been figuring out how to deliver these fragile molecules to the right places in the body. Genedit designs polymer nanoparticles of varied size, charge, and composition that can selectively deliver genetic payloads to specific tissues such as in the lungs or the central nervous system.
News & Insights

Explore Companies

Newleos Therapeutics
Transforming the treatment of anxiety and other neuropsychiatric disorders

Grove Biopharma
Putting protein-like drugs inside cells to fight cancer and neurodegeneration

Syntax Bio
Programming stem cells to differentiate into desired cell types, faster

Fable Therapeutics
Using state-of-the-art machine learning models to create custom-build protein drugs